Hillstar Bio Funding: $67M Raised, Series A (2025)

Hillstar Bio funding overview

Hillstar Bio is based in Boston, MA. Hillstar Bio has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2025. The round record for Hillstar Bio runs through 2025; nothing later has been disclosed. Investors on record include Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience. 5 distinct backers are named across the disclosed rounds.

Hillstar Bio at a glance

Total raised: $67M
Latest round: Series A
Latest round date: March 2025
Headquarters: Boston, MA
Notable investors: Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience

Frequently asked about Hillstar Bio funding

How much has Hillstar Bio raised?: Hillstar Bio has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Hillstar Bio?: Droia Ventures, Frazier Life Sciences, Novo Holdings A/S, LifeArc Ventures, Hummingbird Bioscience are named among the investors backing Hillstar Bio.
What was the latest Hillstar Bio funding round?: The most recent disclosed round is a Series A, announced in March 2025.
Where is Hillstar Bio based?: Hillstar Bio is based in Boston, MA.
When did Hillstar Bio last raise?: The last disclosed Hillstar Bio round closed in March 2025 at Series A.

Hillstar Bio totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Boston below to benchmark round size and investor mix.

Hillstar Bio Funding: $67M Raised, Series A (2025)

Hillstar Bio funding overview

Hillstar Bio at a glance

Frequently asked about Hillstar Bio funding

Companies related to Hillstar Bio (27)

Browse related funding lists (8)